PDSS1 and hepatocellular carcinoma: We found that HCC patients with high expression levels of PDSS1 show poor overall survival (OS) (p = 0.001), disease-specific survival (DSS) (p = 0.003), and progress-free interval (PFI) (p = 0.031) (Figure 2C).